| Literature DB >> 34931167 |
Duc Trong Quach1,2, Lan Thi-Ngoc Tran3, Truc Le-Thanh Tran2, Vy Ly-Thao Tran2, Nhan Quang Le2, Toru Hiyama4.
Abstract
Background and Aims: Age cutoff is an important factor in deciding whether esophagogastroduodenoscopy (EGD) is necessary for patients presenting with upper gastrointestinal symptoms. However, the cutoff value is significantly different across populations. We aimed to determine the age cutoff for EGD that assures a low rate of missing upper gastrointestinal malignancy (UGIM) and to assess the yield of prompt EGD in Vietnamese patients presenting with upper gastrointestinal symptoms.Entities:
Mesh:
Year: 2021 PMID: 34931167 PMCID: PMC8684522 DOI: 10.1155/2021/1184848
Source DB: PubMed Journal: Can J Gastroenterol Hepatol ISSN: 2291-2789
Figure 1Data retrieval procedures of the study.
Endoscopic and histopathologic characteristics of the upper gastrointestinal malignancies.
| Endoscopic and histopathologic characteristics |
|
|---|---|
| Esophagus ( | |
| Location, | |
| Cervical | 14 (3.2) |
| Upper thoracic | 60 (13.6) |
| Middle thoracic | 136 (30.9) |
| Lower thoracic | 188 (42.7) |
| Abdominal | 42 (9.5) |
|
| |
| Endoscopic type1, | |
| Type 0 | 1 (0.2) |
| Type 1 | 247 (56.1) |
| Type 2 | 153 (34.8) |
| Type 3 | 17 (3.9) |
| Type 4 | 18 (4.1) |
| Type 5 | 4 (0.9) |
|
| |
| Pathologic type, | |
| Squamous cell carcinoma | 375 (85.2) |
| Adenocarcinoma | 49 (11.1) |
| Others | 16 (3.7) |
|
| |
| Stomach ( | |
| Location, | |
| Upper part | 109 (6.3) |
| Middle part | 365 (21.0) |
| Lower part | 975 (56.2) |
| ≥ 2 parts involved | 286 (16.5) |
|
| |
| Endoscopic type2, | |
| Type 0 | 86 (5.0) |
| Type 1 | 186 (10.7) |
| Type 2 | 948 (54.6) |
| Type 3 | 301 (17.3) |
| Type 4 | 212 (12.2) |
| Type 5 | 2 (0.1) |
|
| |
| Pathologic type, | |
| Adenocarcinoma | |
| Intestinal type | 1250 (72.0) |
| Diffuse type | 418 (24.1) |
| Lymphoma | 59 (3.4) |
| Others | 8 (0.5) |
|
| |
| Duodenum ( | |
| Location, | |
| Superior duodenal flexure | 3 (11.5) |
| Descending part | 23 (88.5) |
|
| |
| Endoscopic type, | |
| Mass | 15 (57.7) |
| Ulcerative | 9 (34.6) |
| Infiltrative ulcerative | 2 (7.7) |
|
| |
| Pathologic type, | |
| Adenocarcinoma | 18 (69.2) |
| Secondary carcinoma (invasion or metastasis) | 4 (15.4) |
| Lymphoma | 2 (7.7) |
| Gastrointestinal stromal tumor | 1 (3.8) |
| Neuroendocrine tumor | 1 (3.8) |
1, 2The endoscopic types of esophageal and gastric cancers were reported according to the classifications of the Japanese Esophageal Society and the Japanese Gastric Cancer Association, respectively.
Age and sex distribution of the patients with upper gastrointestinal malignancy during the 2014–2019 period.
| Year of endoscopy and number of patients with upper gastrointestinal malignancy | Total |
| |||||||
|---|---|---|---|---|---|---|---|---|---|
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | ||||
| Age | Median (IQR) | 58 (50–67) | 58 (50–67) | 56.5 (48–66) | 58 (51–67) | 58 (50–65) | 56 (51–63) | 57 (50–66) | 0.399 |
| Minimum | 23 | 14 | 26 | 20 | 28 | 20 | 14 | — | |
| Maximum | 90 | 90 | 92 | 94 | 89 | 86 | 94 | — | |
|
| |||||||||
| Age range | <40 ( | 22 (6.4) | 24 (6.3) | 24 (6.1) | 24 (6.9) | 28 (7.3) | 23 (6.6) | 145 (6.6) | 0.985 |
| ≥40 ( | 324 (93.6) | 357 (93.7) | 372 (93.9) | 322 (93.1) | 355 (92.7) | 323 (93.4) | 2053 (39.4) | ||
|
| |||||||||
| Sex | Female ( | 97 (28.0) | 107 (28.1) | 127 (32.1) | 82 (23.7) | 111 (29.0) | 94 (27.2) | 618 (28.1) | 0.244 |
| Male ( | 249 (72.0) | 274 (71.9) | 269 (67.9) | 264 (76.3) | 272 (71.0) | 252 (72.8) | 1580 (71.9) | ||
IQR: interquartile range.
Age cutoff of esophagogastroduodenoscopy according to the cumulative percentage of missed upper gastrointestinal malignancy.
| Age cutoff (years) | Female | Male | Total | |||
|---|---|---|---|---|---|---|
|
| Cumulative % (95% CI) |
| Cumulative % (95% CI) |
| Cumulative % 95% CI) | |
| ≤30 | 11 | 1.8 (0.9–3.1) | 9 | 0.6 (0.3–1.1) | 20 | 0.9 (0.6–1.4) |
| ≤35 | 44 | 7.1 (5.2–9.4) | 28 | 1.8 (1.2–2.5) | 72 | 3.3 (2.6–4.1) |
| ≤40 | 78 | 12.6 (10.1–15.5) | 67 | 4.2 (3.3–5.4) | 145 | 6.6 (5.6–7.7) |
| ≤45 | 132 | 21.4 (18.0–24.6) | 169 | 10.7 (9.2–12.3) | 301 | 13.7(12.3–15.2) |
| ≤50 | 191 | 30.9 (27.3–34.7) | 334 | 21.1 (19.2–23.2) | 525 | 23.9 (22.1–25.7) |
| ≤55 | 268 | 43.4 (39.4–47.4) | 620 | 39.2 (36.8–41.7) | 888 | 40.4 (38.3–42.5) |
CI: confidence interval.
Yield of esophagogastroduodenoscopy for upper gastrointestinal malignancy with prompt endoscopy strategy.
| Age range (years) | Number of endoscopic procedures | Upper gastrointestinal malignancies | ||
|---|---|---|---|---|
|
| Proportions of procedures % (95% CI) |
| Yield per 1000 procedures % (95% CI) | |
| <30 | 70 600 | 14.9 (14.8–15.0) | 20 | 0.3 (0.2–0.4) |
| 30– < 35 | 57 697 | 12.2 (12.1–12.3) | 52 | 0.9 (0.7–1.2) |
| 35– < 40 | 69 131 | 14.6 (14.5–14.7) | 73 | 1.1 (0.8–>1.3) |
| 40– < 45 | 67 318 | 14.2 (14.1–14.3) | 156 | 2.3 (2.0–2.7) |
| 45– < 50 | 61 660 | 13.0 (12.9–13.1) | 224 | 3.6 (3.2–4.1) |
| 50– < 55 | 52 808 | 11.2 (11.1–11.3) | 363 | 6.9 (6.2–7.6) |
| 55– < 60 | 40 036 | 8.5 (8.4–8.6) | 359 | 9.0 (8.1–9.9) |
| 60– < 65 | 26 807 | 5.6 (5.6–5.7) | 324 | 12.1 (10.8–13.5) |
| 65– < 70 | 14 079 | 3.0 (2.9–3.0) | 258 | 18.3 (16.2–20.7) |
| ≥70 | 12 608 | 2.6 (2.6–2.7) | 369 | 29.3 (26.4–32.4) |
CI: confidence interval.